Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Now that the litigation between Moore and TPL is over

My guess is, PTSC will make its announcement about the shareholder meeting this week if not today .I have suspected for a while that settlement talks between Moore and TPL was the reason that PTSC hasn't set the date for the annual shareholder meeting. I was pretty much convinced of this when I read on the court website of a partial dismissal and reported it ihere.. Good luck to all of us. Watch out infringers ....here they come united.

Share
New Message
Please login to post a reply